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We read with great interest a recent review 
by Sacks et al. (2011) and would like to 
add some comments to facilitating effects 
of particulate matter (PM) on pre  existing 
respiratory diseases. First of all, the adverse 
effects of PM/diesel exhaust particles (DEP) 
on chronic obstructive pulmonary disease 
(COPD) patho  physiology seem to be con­
troversial. Subjects with pulmonary emphy­
sema are epidemiologically susceptible to 
PM (Dockery et al. 1993; Euler et al. 1987; 
MacNee and Donaldson 2003; Thishan 
Dharshana and Coowanitwong 2008). 
Further, as noted by Sacks et al. (2011), 
Lopes et al. (2009) have experimentally 
shown that chronic (2 months) exposure 
to an ambient level (mean concentration, 
34 µg/m3) of PM10 (PM < 10 µm in aero­
dynamic diameter) worsens murine emphy­
sema induced by papain. In contrast, in our 
previous study (Inoue et al. 2010) we did not 
obtain apparent evidence that a single intra­
tracheal administration of DEP [200 µg/
animal, a dose high enough to worsen infec­
tious lung injury (Takano et al. 2002)] exac­
erbates porcine pancreatic elastase–elicited 
pulmonary emphysema in mice. Possible 
explanations for this opposite phenomenon 
may include differences in animal strains or 
species, pathological conditions (type and/or   
degree of emphysematous inflammation), 
and/or DEP exposure protocols (route, dose, 
timing, duration, and/or terminal point). 
Additional in­depth studies will be required 
to conclude PM/DEP has adverse effects on 
COPD pathophysiology. 
Secondly, from a biological point of 
view, pulmonary fibrosis (PF) should be 
added to the list of PM­susceptible respi­
ratory diseases. Recently, Decologne et al. 
(2010) showed that exposure to carbon black 
nano  particles exacerbates bleomycin­induced 
PF in mice. More recently, we demonstrated 
that a single intra  tracheal instillation of tiny 
carbon black nano  particles (14 nm) at a dose 
of 10 µg/mouse aggravates PF, suggesting 
that exposure to trace amounts of PM can 
exacerbate patho  physiology (Kamata et al. 
2011). Accordingly, careful attention should 
be paid to PF patients who are at risk of 
environmental and occupational exposure 
to PM, although further basic and clinical 
research is necessary. 
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Editor’s note: In accordance with journal 
policy, Sacks et al. were asked whether they 
wanted to respond to this letter, but they chose 
not to do so.
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